Vimarsana
Biggest News Aggregation in the World

Discogenic Cells News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Discogenic Cells. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Discogenic Cells Today - Breaking & Trending Today

DiscGenics partners with VA Department for biologic disc replacements - Vimarsana News

DiscGenics partners with VA Department for biologic disc replacements

DiscGenics is partnering with the U.S. Department of Veterans Affairs to conduct research into forming tissue-engineered discs, according to an Oct. 18 news release.

DiscGenics Announces Positive Two-Year Clinical Data from Study of Discogenic Progenitor Cell Therapy for Degenerative Disc Disease - Vimarsana News

DiscGenics Announces Positive Two-Year Clinical Data from Study of Discogenic Progenitor Cell Therapy for Degenerative Disc Disease

/PRNewswire/ -- DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and...

DiscGenics to Present at 2022 Cell & Gene Meeting on the Mesa - Vimarsana News

DiscGenics to Present at 2022 Cell & Gene Meeting on the Mesa

/PRNewswire/ -- DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and...

DiscGenics Announces Presentation of Positive Interim Clinical Data from Phase 1/2 Study of Cell Therapy for Degenerative Disc Disease - Vimarsana News

DiscGenics Announces Presentation of Positive Interim Clinical Data from Phase 1/2 Study of Cell Therapy for Degenerative Disc Disease

/PRNewswire/ -- DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and...

DiscGenics Announces Presentation of Positive Interim Clinical Data from Phase 1/2 Study of Cell Therapy for Degenerative Disc Disease - Vimarsana News

DiscGenics Announces Presentation of Positive Interim Clinical Data from Phase 1/2 Study of Cell Therapy for Degenerative Disc Disease

/PRNewswire/ -- DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and...